Clinical Trial Update: Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of HL-040XC for essential hypertension and hyperlipidemia has completed; results are not provided in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hyperlipidemia

Drugs mentioned

• HL-040XC

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Essential Hypertension, Hyperlipidemia | Phase 3 | Status: COMPLETED